Literature DB >> 9434627

Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes.

P C Yaeger1, T L Masi, J L de Ortiz, F Binette, R Tubo, J M McPherson.   

Abstract

Reexpression of aggrecan and type II collagen genes in dedifferentiated adult human articular chondrocytes (AHAC) in suspension culture varied widely depending on the specific lot of bovine serum used to supplement the culture medium. Some lots of serum provided strong induction of aggrecan and type II collagen expression by AHAC while others did not stimulate significant production of these hyaline cartilage extracellular matrix molecules even following several weeks in culture. Addition of 50 ng/ml insulin-like growth factor-I (IGF-I) to a deficient serum lot significantly enhanced its ability to induce aggrecan and type II collagen mRNA. Given this observation, IGF-I and other growth factors were tested in defined serum-free media for their effects on the expression of these genes. Neither IGF-I nor insulin nor transforming growth factor beta (TGF-beta) alone stimulated induction of aggrecan or type II collagen production by dedifferentiated AHAC. However, TGF-beta 1 or TGF-beta 2 combined with IGF-I or insulin provided a strong induction as demonstrated by RNase protection and immunohistochemical assays. Interestingly, type I collagen, previously shown to be downregulated in serum supplemented suspension cultures of articular chondrocytes, persisted for up to 12 weeks in AHAC cultured in defined medium supplemented with TGF-beta and IGF-I.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434627     DOI: 10.1006/excr.1997.3781

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  47 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model.

Authors:  F Kandziora; R Pflugmacher; M Scholz; J Schäfer; G Schollmeier; G Schmidmaier; G Duda; M Raschke; N P Haas
Journal:  Eur Spine J       Date:  2002-11-08       Impact factor: 3.134

3.  Synergistic action of fibroblast growth factor-2 and transforming growth factor-beta1 enhances bioprinted human neocartilage formation.

Authors:  Xiaofeng Cui; Kurt Breitenkamp; Martin Lotz; Darryl D'Lima
Journal:  Biotechnol Bioeng       Date:  2012-04-08       Impact factor: 4.530

4.  Identification of the chondrocyte lineage using microfibril-associated glycoprotein-2, a novel marker that distinguishes chondrocytes from synovial cells.

Authors:  Stephen Rapko; Mindy Zhang; Brenda Richards; Elizabeth Hutto; Sandra Dethlefsen; Stephen Duguay
Journal:  Tissue Eng Part C Methods       Date:  2010-05-10       Impact factor: 3.056

Review 5.  Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.

Authors:  Catherine Baugé; Nicolas Girard; Eva Lhuissier; Celine Bazille; Karim Boumediene
Journal:  Aging Dis       Date:  2013-12-17       Impact factor: 6.745

6.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.

Authors:  Andre F Steinert; Glyn D Palmer; Carmencita Pilapil; Ulrich Nöth; Christopher H Evans; Steven C Ghivizzani
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

7.  Long term results after implantation of tissue engineered cartilage for the treatment of osteochondral lesions in a minipig model.

Authors:  J P Petersen; P Ueblacker; C Goepfert; P Adamietz; K Baumbach; A Stork; J M Rueger; R Poertner; M Amling; N M Meenen
Journal:  J Mater Sci Mater Med       Date:  2007-10-24       Impact factor: 3.896

8.  Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells.

Authors:  Haili Wang; Markus Kroeber; Michael Hanke; Rainer Ries; Carsten Schmid; Wolfgang Poller; Wiltrud Richter
Journal:  J Mol Med (Berl)       Date:  2003-12-11       Impact factor: 4.599

9.  Improving in vitro generated cartilage-carrier-constructs by optimizing growth factor combination.

Authors:  Katharina Wiegandt; Christiane Goepfert; Ralf Pörtner
Journal:  Open Biomed Eng J       Date:  2007-12-13

10.  Featured Article: In vitro development of personalized cartilage microtissues uncovers an individualized differentiation capacity of human chondrocytes.

Authors:  Frank Martin; Mario Lehmann; Ulrich Sack; Ursula Anderer
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.